You are here: Industry Insights > Diabetes

News List

Zydus Cadila gets tentative USFDA nod for empagliflozin and linagliptin tablets expresspharma
September 18, 2020
They are oral diabetes medicines that help control blood sugar levels.
ReShape Announces Positive Preclinical Results for Diabetes Neuromodulation Device americanpharmaceuticalreview
September 17, 2020
ReShape Lifesciences announced preclinical research demonstrating the Company's investigational Diabetes Bloc-Stim Neuromodulation? (DBSN?) proprietary device for the treatment of type 2 diabetes mellitus (T2DM) was well-tolerated and met the study ...
UK launch for Novo's new diabetes pill pharmatimes
September 02, 2020
Novo Nordisk has launched in the UK the first 'protein in a pill' treatment for type II diabetes.
Mylan, Biocon Biologics Announce Launch of Semglee in U.S. americanpharmaceuticalreview
September 01, 2020
Mylan and Biocon Biologics India announced the U.S. launch of Semglee? (insulin glargine injection) in vial and pre-filled pen presentations, approved to help control high blood sugar in adult and pediatric patients with type 1 diabetes and adults with...
Diabetes drug, Dapagliflozin shows benefits in patients with CKD expresspharma
September 01, 2020
The drug, on top of standard of care, reduced the composite measure of worsening of renal function or risk of cardiovascular (CV) or renal death by 39 per cent.
Biocon Biologics and Mylan launch Semglee (insulin glargine injection) in US expresspharma
September 01, 2020
Mylan is offering Semglee at a wholesale acquisition cost (WAC) of $147.98 per package of five 3ml pens and $98.65 per 10ml vial.
Empagliflozin reduced risk of death and hospitalisation for heart failure by 25 per cent in adults expresspharma
August 31, 2020
Boehringer Ingelheim announced the full results from the EMPEROR-Reduced Phase III trial in adults with heart failure with reduced ejection fraction, with and without diabetes.
Artificial pancreas for type 1 diabetes control given nod by FDA europeanpharmaceuticalreview
August 28, 2020
The all-in-one, Control-IQ system controlled the blood glucose levels of children aged six and over more successfully than standard technologies in a clinical trials.
Precigen ActoBio Announces Positive Topline Results from Type 1 Diabetes Treatment Study americanpharmaceuticalreview
August 13, 2020
Precigen ActoBio has met the primary endpoint assessing safety and tolerability in the Phase 1b monotherapy portion of the ongoing Phase 1b/2a clinical study investigating AG019 ActoBiotics? for the treatment of early-onset type 1 diabetes (T1D).
Lupin gets tentative approval from US FDA for empagliflozin tablets expresspharma
August 05, 2020
Empagliflozin tablets are used to treat type 2 diabetes mellitus as an adjunct to diet and exercise.